180 results on '"Fung, Chunkit"'
Search Results
2. Cardiovascular Risks in Testicular Cancer: Assessment, Prevention, and Treatment
3. Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy
4. How to Manage Cisplatin-Based Chemotherapy–Related Cardiovascular Disease in Patients With Testicular Cancer
5. Exemestane Treatment in a Male Patient With Concurrent Breast and Prostate Cancers: A Case Report.
6. High‐dose vitamin D to attenuate bone loss in patients with prostate cancer on androgen deprivation therapy: A phase 2 RCT.
7. Comprehensive Audiologic Analyses After Cisplatin-Based Chemotherapy.
8. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
9. Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments
10. Cisplatin, environmental metals, and cardiovascular disease: an urgent need to understand underlying mechanisms
11. The association of delay in curative intent treatment with survival among breast cancer patients: findings from the Women’s Health Initiative
12. Impact of pain and adverse health outcomes on long-term US testicular cancer survivors.
13. Adolescent and Young Adult Germ Cell Tumors: Epidemiology, Genomics, Treatment, and Survivorship.
14. Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score
15. State of Cancer Care in America: Achieving Cancer Health Equity Among Sexual and Gender Minority Communities.
16. Novel Biomarkers Of Treatment-Induced Muscle Damage, Exercise And Fatigue: An RCT In Breast Cancer Patients: 3540 Board #361 May 29 2:30 PM - 4:00 PM
17. Exercise Recommendations for the Management of Symptoms Clusters Resulting From Cancer and Cancer Treatments
18. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial
19. Association of falls with health-related quality of life (HRQOL) in older cancer survivors: A population based study
20. Novel physical activity interventions for older patients with prostate cancer on hormone therapy: A pilot randomized study
21. Long-term Morbidity of Testicular Cancer Treatment
22. Treatment of Metastatic Prostate Cancer in Older Adults
23. Impact of Bladder Cancer on Health Related Quality of Life in 1,476 Older Americans: A Cross-Sectional Study
24. Response to Crevenna and Ashbury, Vallance and Bolam, and Crevenna and Keilani regarding the effects of exercise on chemotherapy-induced peripheral neuropathy
25. Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study
26. Risk of solid cancer after chemotherapy
27. Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy.
28. Yoga for the Management of Cancer Treatment-Related Toxicities
29. Lack of hydroxyurea‐associated mutagenesis in pediatric sickle cell disease patients.
30. Comprehensive association analysis of speech recognition thresholds after cisplatin‐based chemotherapy in survivors of adult‐onset cancer.
31. AGS and NIA bench‐to bedside conference summary: Cancer and cardiovascular disease.
32. Second Primary Head and Neck Cancer After Hodgkin Lymphoma: A Population-Based Study of 44,879 Survivors of Hodgkin Lymphoma
33. MP51-11 DOES HYPOGONADISM (OR LOW T) PRESENT DIFFERENTLY IN THE INFERTILE MALE?
34. Medicare Accountable Care Organizations: Post-acute Care Use and Post-surgical Outcomes in Urologic Cancer Surgery.
35. Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy.
36. Increased risk of high-grade prostate cancer among testicular cancer survivors.
37. Complications associated with chemotherapy in testicular cancer management
38. Testicular Cancer Survivorship: Looking Back to Move Forward.
39. Tobacco Dependence Treatment: Examining cessation effectiveness in oncology settings.
40. Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors
41. Surviving Testicular Cancer: The Role of the Contralateral Testicle.
42. Relationship of Cisplatin-Related Adverse Health Outcomes With Disability and Unemployment Among Testicular Cancer Survivors.
43. Solid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24 900 Survivors.
44. Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management.
45. Effects of exercise on inflammation in patients receiving chemotherapy: a nationwide NCORP randomized clinical trial.
46. Bladder cancer in the elderly patient: challenges and solutions
47. Effects of a Home‐based Exercise Program on Anxiety and Mood Disturbances in Older Adults with Cancer Receiving Chemotherapy.
48. Increased Risk of Cardiovascular Sequelae in Survivors of Male Germ Cell Cancer.
49. Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.
50. A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.